One in four heart attack patients have atypical symptoms such as breathing difficulties, extreme exhaustion, and abdominal pain, according to a study published today in European Heart Journal—Acute Cardiovascular Care, a journal of the European Society of Cardiology (ESC). Patients with atypical symptoms were less likely to receive emergency help and more likely to die …
A revolutionary assistive technology being developed by GP Dr. Nick Gompertz with a team of researchers at the University of Bath hopes to offer people with conditions such as Motor Neurone Disease (MND) new ways of communicating via a computer.
By discovering a potential new cellular mechanism for migraines, researchers may have also found a new way to treat chronic migraine.
A new mutation found in a gene associated with an increased risk of atrial fibrillation poses a significantly increased risk for heart failure in Black people.
According to a new study published in the journal Research in Social and Administrative Pharmacy, hospitals that participate in the 340B Drug Pricing Program provide more medication access services—which are services that help remove barriers to accessing necessary medications—than comparably sized non-340B hospitals.
A Yale-led study reveals that new medicines and vaccines approved for use in the United States are often unavailable in countries that hosted their clinical trials, suggesting that the benefits of drug research are not being shared equitably among populations that participate in testing.
You might gawk at Premier League footballers’ million dollar salaries but playing careers are short and can sometimes be curtailed by injury, illness or poor form.
Two doses of the Pfizer-BioNTech COVID-19 vaccine provide more than 95% protection against infection, hospitalisation, severe illness, and death, including among the elderly, according to the first national-level observational assessment of its effectiveness in Israel, published in The Lancet.
With around 30 percent of the U.S. population now fully vaccinated, the rate of daily vaccinations has started to slow, raising concerns that greater efforts and investments may be needed to reach higher coverage levels. A study published in the Journal of Infectious Diseases on May 6 shows the lives, hospitalizations, and costs that can …